BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27841001)

  • 1. Midazolam and ropivacaine act synergistically to inhibit bone cancer pain with different mechanisms in rats.
    Guo CH; Bai L; Wu HH; Yang J; Cai GH; Zeng SX; Wang X; Wu SX; Ma W
    Oncol Rep; 2017 Jan; 37(1):249-258. PubMed ID: 27841001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.
    Guo CH; Bai L; Wu HH; Yang J; Cai GH; Wang X; Wu SX; Ma W
    Int J Mol Med; 2016 Nov; 38(5):1433-1442. PubMed ID: 28025994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting spinal neuron-astrocytic activation correlates with synergistic analgesia of dexmedetomidine and ropivacaine.
    Wu HH; Yin JB; Zhang T; Cui YY; Dong YL; Chen GZ; Wang W
    PLoS One; 2014; 9(3):e92374. PubMed ID: 24658263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analgesic effects of triptolide in the bone cancer pain rats via inhibiting the upregulation of HDACs in spinal glial cells.
    Hu XF; He XT; Zhou KX; Zhang C; Zhao WJ; Zhang T; Li JL; Deng JP; Dong YL
    J Neuroinflammation; 2017 Nov; 14(1):213. PubMed ID: 29096654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic Effect of Intrathecal Administration of Chemokine Receptor CCR2 Antagonist is Related to Change in Spinal NR2B, nNOS, and SIGIRR Expression in Rat with Bone Cancer Pain.
    Ren F; Jiao H; Cai H
    Cell Biochem Biophys; 2015 Jun; 72(2):611-6. PubMed ID: 25653100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
    Hu XM; Liu YN; Zhang HL; Cao SB; Zhang T; Chen LP; Shen W
    J Neurochem; 2015 Feb; 132(4):452-63. PubMed ID: 25393328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Roles of Chemokine CXCL13 in the Development of Bone Cancer Pain and the Regulation of Morphine Analgesia in Rats.
    Bu HL; Xia YZ; Liu PM; Guo HM; Yuan C; Fan XC; Huang C; Wen YY; Kong CL; Wang T; Ma LT; Li XX; Zhang HW; Zhang LR; Ma MY; Ai YQ; Zhang W
    Neuroscience; 2019 May; 406():62-72. PubMed ID: 30826523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring μ-opioid receptor in spinal cord.
    Hou X; Weng Y; Ouyang B; Ding Z; Song Z; Zou W; Huang C; Guo Q
    Brain Res; 2017 Aug; 1669():97-105. PubMed ID: 28559159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrathecal injection of AG-490 reduces bone-cancer-induced spinal cord astrocyte reaction and thermal hyperalgesia in a mouse model].
    Zhang J; Ren B; Ni K; Liu Y; Ma Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1182-1187. PubMed ID: 30643061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The analgesic effects of pioglitazone in the bone cancer pain rats via regulating the PPARγ/PTEN/mTOR signaling pathway in the spinal dorsal horn.
    Gu W; Sun Y; Gu W; Huang Y; Bo J; Zhou L; Ma Z; Gu X; Zhang W
    Biomed Pharmacother; 2020 Nov; 131():110692. PubMed ID: 32942156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockage of spinal endothelin A receptors attenuates bone cancer pain via regulation of the Akt/ERK signaling pathway in mice.
    Han MM; Yang CW; Cheung CW; Li J
    Neuropeptides; 2018 Apr; 68():36-42. PubMed ID: 29395120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XPro1595 ameliorates bone cancer pain in rats via inhibiting p38-mediated glial cell activation and neuroinflammation in the spinal dorsal horn.
    Zhou KX; He XT; Hu XF; Zhao WJ; Li CX; Zhang C; Zhang T; Gu ZX; Deng JP; Dong YL
    Brain Res Bull; 2019 Jul; 149():137-147. PubMed ID: 31002915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline attenuates bone cancer pain in rats by inhibiting NF-κB in spinal astrocytes.
    Song ZP; Xiong BR; Guan XH; Cao F; Manyande A; Zhou YQ; Zheng H; Tian YK
    Acta Pharmacol Sin; 2016 Jun; 37(6):753-62. PubMed ID: 27157092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin exerts antinociceptive effects by inhibiting the activation of astrocytes in spinal dorsal horn and the intracellular extracellular signal-regulated kinase signaling pathway in rat model of chronic constriction injury.
    Ji FT; Liang JJ; Liu L; Cao MH; Li F
    Chin Med J (Engl); 2013 Mar; 126(6):1125-31. PubMed ID: 23506591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats.
    Song XS; Cao JL; Xu YB; He JH; Zhang LC; Zeng YM
    Acta Pharmacol Sin; 2005 Jul; 26(7):789-98. PubMed ID: 15960884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoidan attenuates the existing allodynia and hyperalgesia in a rat model of neuropathic pain.
    Hu C; Zhang G; Zhao YT
    Neurosci Lett; 2014 Jun; 571():66-71. PubMed ID: 24792391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord.
    Wang LN; Yao M; Yang JP; Peng J; Peng Y; Li CF; Zhang YB; Ji FH; Cheng H; Xu QN; Wang XY; Zuo JL
    Mol Pain; 2011 Jul; 7():48. PubMed ID: 21722369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JNK in spinal cord facilitates bone cancer pain in rats through modulation of CXCL1.
    Wang ZL; Du TT; Zhang RG
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):88-94. PubMed ID: 26838746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice.
    Yokai M; Kurihara T; Miyata A
    Mol Pain; 2016; 12():. PubMed ID: 27175011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol attenuates bone cancer pain through the inhibition of spinal glial activation and CX3CR1 upregulation.
    Cheng W; Zhao Y; Liu H; Fan Q; Lu FF; Li J; Yin Q; Yan CD
    Fundam Clin Pharmacol; 2014 Dec; 28(6):661-70. PubMed ID: 24872145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.